Advertisement

Prognostic Impact of Total and Tyrosine Phosphorylated GIV/Girdin in Breast Cancers

Researchers presented the first exploratory biomarker study conducted on a cohort of 187 patients with breast cancer to evaluate the prognostic role of total GIV (tGIV) and tyrosine phosphorylated GIV (pYGIV) across the various molecular subtypes.

 FASEB J

click me